X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA STRIDES SHASUN LTD ALEMBIC PHARMA/
STRIDES SHASUN LTD
 
P/E (TTM) x 26.5 14.1 187.8% View Chart
P/BV x 6.1 1.9 316.8% View Chart
Dividend Yield % 0.8 0.5 142.8%  

Financials

 ALEMBIC PHARMA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
STRIDES SHASUN LTD
Mar-16
ALEMBIC PHARMA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs7921,413 56.0%   
Low Rs443848 52.2%   
Sales per share (Unadj.) Rs167.0353.3 47.3%  
Earnings per share (Unadj.) Rs38.223.4 163.2%  
Cash flow per share (Unadj.) Rs42.041.0 102.5%  
Dividends per share (Unadj.) Rs4.005.00 80.0%  
Dividend yield (eoy) %0.60.4 146.5%  
Book value per share (Unadj.) Rs84.9320.4 26.5%  
Shares outstanding (eoy) m188.5289.35 211.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.73.2 115.5%   
Avg P/E ratio x16.248.3 33.5%  
P/CF ratio (eoy) x14.727.6 53.3%  
Price / Book Value ratio x7.33.5 206.2%  
Dividend payout %10.521.4 49.0%   
Avg Mkt Cap Rs m116,383100,988 115.2%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m4,2144,988 84.5%   
Avg. sales/employee Rs ThNM6,730.0-  
Avg. wages/employee Rs ThNM1,063.6-  
Avg. net profit/employee Rs ThNM445.5-  
INCOME DATA
Net Sales Rs m31,48731,564 99.8%  
Other income Rs m551,212 4.5%   
Total revenues Rs m31,54232,776 96.2%   
Gross profit Rs m10,0605,213 193.0%  
Depreciation Rs m7221,573 45.9%   
Interest Rs m371,803 2.0%   
Profit before tax Rs m9,3563,049 306.8%   
Minority Interest Rs m0127 0.0%   
Prior Period Items Rs m-2-27 5.6%   
Extraordinary Inc (Exp) Rs m0-371 0.0%   
Tax Rs m2,160689 313.7%   
Profit after tax Rs m7,1942,089 344.3%  
Gross profit margin %31.916.5 193.4%  
Effective tax rate %23.122.6 102.2%   
Net profit margin %22.86.6 345.2%  
BALANCE SHEET DATA
Current assets Rs m15,06635,949 41.9%   
Current liabilities Rs m7,67419,402 39.6%   
Net working cap to sales %23.552.4 44.8%  
Current ratio x2.01.9 105.9%  
Inventory Days Days6771 94.4%  
Debtors Days Days41127 32.0%  
Net fixed assets Rs m8,23734,478 23.9%   
Share capital Rs m377894 42.2%   
"Free" reserves Rs m15,41622,601 68.2%   
Net worth Rs m16,00528,632 55.9%   
Long term debt Rs m027,455 0.0%   
Total assets Rs m24,59476,591 32.1%  
Interest coverage x255.22.7 9,484.6%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x1.30.4 310.7%   
Return on assets %29.45.1 578.5%  
Return on equity %44.97.3 616.0%  
Return on capital %58.78.2 718.4%  
Exports to sales %55.748.1 115.8%   
Imports to sales %10.414.5 72.1%   
Exports (fob) Rs m17,55115,192 115.5%   
Imports (cif) Rs m3,2834,565 71.9%   
Fx inflow Rs m17,81116,612 107.2%   
Fx outflow Rs m5,3185,292 100.5%   
Net fx Rs m12,49311,320 110.4%   
CASH FLOW
From Operations Rs m9,304717 1,298.3%  
From Investments Rs m-3,105-22,284 13.9%  
From Financial Activity Rs m-1,95929,488 -6.6%  
Net Cashflow Rs m4,2408,073 52.5%  

Share Holding

Indian Promoters % 74.1 27.7 267.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 37.8 7.7%  
FIIs % 9.1 8.6 105.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 25.9 53.7%  
Shareholders   49,328 56,241 87.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  BIOCON LTD  J.B.CHEMICALS  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - ABBOTT INDIA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS